Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes

November 13, 2014 updated by: Néstor Vicente-Salar, Universidad Miguel Hernandez de Elche
The purpose of this study is to evaluate modifications of plasma protein carbonyls and malondialdehyde levels in endurance-based athletes after three weeks of pomegranate juice consumption.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Early Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Perform specific endurance training sessions
  • More than 1 hour per session and more than 3 sessions per week
  • Have participated recently in a half marathon or similar event

Exclusion Criteria:

  • Intake of antioxidant or anti-inflammatory supplementation
  • Present a chronic disorder
  • Non-smoker
  • No-alcoholic beverage consumption

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Arm that followed all the protocols with the exception of the pomegranate juice intake.
Experimental: Pomegranate Juice
Arm that followed all the protocols and the pomegranate juice intake.
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Other Names:
  • Zumo de Granada Vitalgrana
Experimental: Pomegranate Juice Dilution
Arm that followed all the protocols and the pomegranate juice dilution (1:1) intake.
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Other Names:
  • Zumo de Granada Vitalgrana

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein carbonyls levels changes in plasma
Time Frame: day 0 and 22
Protein carbonyl derivatives were determined using an adaptation of the colorimetric method published in Levine et al. (1994) based in the formation of a stable 2,4-dinitrophenyl (DNP) hydrazone product after the addition of 2,4-dinitrophenylhydrazine (DNPH) to tha plasma. Protein carbonyls were calculated as nmoles·mg-1 protein
day 0 and 22
Malondialdehyde levels changes in plasma
Time Frame: day 0 and 22
Malondialdehyde was determined by high pressure liquid chromatography (HPLC) with fluorescence detection according to the method described by Laporta et al. (2007). Malondialdehyde levels were calculated as nmoles·g-1 protein
day 0 and 22

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood biochemical parameters changes in plasma
Time Frame: day 0 and 22
Blood biochemical parameters is a composite outcome measure consisting in circulating plasma glucose (mg·dL-1), HDL-cholesterol (mg·dL-1), triglycerides (mg·dL-1), ferritin (ng·mL-1), lactate (mg·dL-1), sodium (mEq·L-1), potassium (mEq·L-1), creatine kinase (U·L-1), aspartate aminotransferase (U·L-1) and alanine aminotransferase (U·L-1) were analyzed through biochemistry methods.
day 0 and 22
C-reactive protein levels changes in plasma
Time Frame: day 0 and 22
Determination by immunoassay of C-reactive protein (ng·mL-1) levels in plasma.
day 0 and 22
Soluble E-selectin levels changes in plasma
Time Frame: day 0 and 22
Determination by immunoassay of soluble E-selectin (ng·mL-1) levels in plasma.
day 0 and 22

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Enrique Roche, PhD, University Miguel Hernandez

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

November 10, 2014

First Submitted That Met QC Criteria

November 13, 2014

First Posted (Estimate)

November 18, 2014

Study Record Updates

Last Update Posted (Estimate)

November 18, 2014

Last Update Submitted That Met QC Criteria

November 13, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oxidative Stress

Clinical Trials on Pomegranate juice

3
Subscribe